Release Date: 01/03/18 08:15 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 3.31MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%